BioLine RX Ltd (NASDAQ:BLRX)

0.3672
Delayed Data
As of 3:59pm ET
 -0.0128 / -3.37%
Today’s Change
0.35
Today|||52-Week Range
1.84
-16.03%
Year-to-Date

Today’s Trading

Previous close0.38
Today’s open0.39
Day’s range0.36 - 0.39
Volume1,111,635
Average volume (3 months)1,304,113
Market cap$53.5M
Data as of 3:59pm ET, 05/23/2019

Growth & Valuation

Earnings growth (last year)+22.47%
Earnings growth (this year)+19.05%
Earnings growth (next 5 years)-25.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
AVDLAvadel Pharmaceutica...+0.04+2.68%
ISEEIVERIC bio Inc0.000.00%
--Innovative Pharmaceu...+0.00+2.56%
SMMTSummit Therapeutics ...-0.02-1.22%
Data as of 3:59pm ET, 05/23/2019

Financials

Next reporting dateAugust 7, 2019
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$22.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Philip Adam Serlin
Chief Financial Officer
Mali Zeevi
Corporate headquarters
Modi'in, Tel Aviv

Forecasts